Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9784
Title: A Review on MAGL Inhibitor
Authors: Rathod, Gaurav P.
Keywords: PPR01028
B. Pharm Project Report
Medicinal Chemistry
Monoacyl glycerol lipase (MAGL)
neurotransmitter
cannabinoid receptor
Issue Date: May-2020
Publisher: Institute of Pharmacy, Nirma University, A'bad
Series/Report no.: PPR01028;
Abstract: Monoacyl glycerol lipase (MAGL) enzyme belongs to Serine Hydrolase superfamily. MAGL play a role in catabolism of 2-AG (2-Arachidonyl glycerol). 2-AG is a neurotransmitter in endocannabinoid system. Which have some physiological actions. MAGL gives the Arachidonic acid and Glycerol by degrading 2-AG. This Arachidonic acid producing pro-inflammatory agents like prostaglandins, throxanes. So, the major role of MAGL inhibitors as anti-inflammatory, antinociceptive and anti-cancer agents. Recent studies suggest that the repeated administration of MAGL inhibitor will lost its activity and produced cross tolerance to cannabinoid receptor (CB1). In this review we discuss about the Biochemical and Physiological role of MAGL inhibitors, and various scaffolds which are discovered as potent for inhibition of MAGL
Description: Guided by Prof. Manjunath Ghate
URI: http://10.1.7.192:80/jspui/handle/123456789/9784
Appears in Collections:B. Pharm Project Reports

Files in This Item:
File Description SizeFormat 
PPR01028.pdfPPR010281.02 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.